Capital Flow Monitor · Sponsors · CIK 1865257
Allyx Therapeutics, Inc.
555 Long Wharf Drive, NEW HAVEN, CT, 06511 · (908) 432-2845
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$30.0M
Sold
$26.4M
% sold
88.1%
Investors
32
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | D ·current | 506(b) | $30.0M | $26.4M | 88.1% | 32 | EDGAR ↗ |
| 2026-03-03 | D | 506(b) | $4.0M | $3.3M | 83.1% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Stephen Bloch — Executive Officer / Director, New Haven, CT
- Stephen Strittmatter — Director, New Haven, CT
- Paul Fonteyne — Director, New Haven, CT
- Gregory P Ho — Director, New York, NY
- Robert A Bettigole — Director, New Haven, CT
- Timothy Siegert — Executive Officer, New Haven, CT
- Kevin L. Rakin — Director, Westport, CT
Placement agents
- Supervision Partners Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.